Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 1;25(5):458-464.
doi: 10.1093/jamia/ocx150.

Interactive or static reports to guide clinical interpretation of cancer genomics

Affiliations

Interactive or static reports to guide clinical interpretation of cancer genomics

Stacy W Gray et al. J Am Med Inform Assoc. .

Abstract

Objective: Misinterpretation of complex genomic data presents a major challenge in the implementation of precision oncology. We sought to determine whether interactive genomic reports with embedded clinician education and optimized data visualization improved genomic data interpretation.

Materials and methods: We conducted a randomized, vignette-based survey study to determine whether exposure to interactive reports for a somatic gene panel, as compared to static reports, improves physicians' genomic comprehension and report-related satisfaction (overall scores calculated across 3 vignettes, range 0-18 and 1-4, respectively, higher score corresponding with improved endpoints).

Results: One hundred and five physicians at a tertiary cancer center participated (29% participation rate): 67% medical, 20% pediatric, 7% radiation, and 7% surgical oncology; 37% female. Prior to viewing the case-based vignettes, 34% of the physicians reported difficulty making treatment recommendations based on the standard static report. After vignette/report exposure, physicians' overall comprehension scores did not differ by report type (mean score: interactive 11.6 vs static 10.5, difference = 1.1, 95% CI, -0.3, 2.5, P = .13). However, physicians exposed to the interactive report were more likely to correctly assess sequencing quality (P < .001) and understand when reports needed to be interpreted with caution (eg, low tumor purity; P = .02). Overall satisfaction scores were higher in the interactive group (mean score 2.5 vs 2.1, difference = 0.4, 95% CI, 0.2-0.7, P = .001).

Discussion and conclusion: Interactive genomic reports may improve physicians' ability to accurately assess genomic data and increase report-related satisfaction. Additional research in users' genomic needs and efforts to integrate interactive reports into electronic health records may facilitate the implementation of precision oncology.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Physicians' reasons for not using genomic test results to inform treatment recommendations. Categories of responses are described in the figure.
Figure 2.
Figure 2.
Physicians’ comprehension scores. (A) Overall: This score is defined as the sum of the correct responses to 18 items (6 items for each of the 3 vignettes; range 0–18). (B) Domain-specific: This score is defined as the sum of the correct responses to the domain-specific items from each of the 3 vignettes (range 0–3). Std: standard report; Int: interactive report. Higher scores correspond to better comprehension.
Figure 3.
Figure 3.
Physicians’ average satisfaction score. Responses to 16 items were scored on a 1–4 point Likert scale, with higher scores representing greater satisfaction. The overall satisfaction score was defined as the average of the 16 items.
Figure 4.
Figure 4.
Physicians’ attitudes about provider genomic support that would be helpful. Categories of responses are described in the figure.

References

    1. Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol. 2013;3115:1806–14. - PubMed
    1. Sholl LM, Do K, Shivdasani P et al. , Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight. 2016;1:e87062. - PMC - PubMed
    1. Zehir A, Benayed R, Shah RH et al. , Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23:703–13. - PMC - PubMed
    1. Gagan J, Van Allen EM. Next-generation sequencing to guide cancer therapy. Genome Med. 2015;7:80. - PMC - PubMed
    1. Le Tourneau C, Delord JP, Goncalves A et al. , Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 2015;16:1324–34. - PubMed

Publication types